News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Innate Pharma Prices IPO At $5.24 To $6.06 Per Share


10/20/2006 2:02:49 PM

Innate Pharma SA, a French drug developer, has set the terms of its public offering at EUR4.15 to EUR4.80 ($5.24 to $6.06) per share.

>>> Discuss This Story




comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES